QCM Cayman’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

QCM Cayman’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,697	Closed	-$213K	–	71
2022 Q3	$213K	Buy	+10,697	New	+$141K	3.11%	18

QCM Cayman's FMTX Position: Q4 2022 in Review

QCM Cayman sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 10,697 shares — an estimated $213K sold.

QCM Cayman first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $213K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

QCM Cayman reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
QCM Cayman sold 10,697 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $213K.
QCM Cayman first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
QCM Cayman's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $213K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on QCM Cayman's 13F filing for Q4 2022, filed 31 Jan 2023.